凍結組織サンプル市場は、2021 年の 44,399.07 千米ドルから 2028 年までに 105,045.91 千米ドルに達すると予測されています。市場は、2021 年から 2028 年の間に 13.1% の CAGR で成長すると推定されています。
凍結組織サンプルは、次世代シーケンシング、翻訳後タンパク質修飾のためのウェスタンブロッティング、質量分析、定量的リアルタイムポリメラーゼ連鎖反応などの分析に適しています。凍結組織サンプルは、特にストランドが 50 ペアよりも長くなければならない場合に、DNA および RNA シーケンスのゴールド スタンダードです。凍結組織サンプルは、タンパク質が未変性の状態で保存されているため、免疫組織化学にも役立ちます。
戦略的洞察
世界の凍結組織サンプル市場の成長は、さまざまな研究および治療分野での凍結組織サンプルの適用、および癌の有病率の上昇による凍結組織サンプルの使用の増加。ただし、凍結組織サンプルの保存と維持に関連するリスクは、世界の凍結組織サンプル市場の成長をある程度妨げています。
凍結組織サンプル市場における収益性の高い地域< /h3>
癌の有病率の上昇による凍結組織サンプルの適用の増加
癌の有病率の上昇による凍結組織サンプルの適用の増加
2020 年に Cancer Research UK が発表したデータによると、英国では毎年約 16 万人ががんで死亡しています。さらに、Globocan のレポートによると、2020 年には、女性の乳がんが最も多く診断されたがんとして肺がんを上回り、推定 230 万件の新規症例 (11.7%) が続き、肺 (11.4%)、結腸直腸 (10.0%)、前立腺が続きました。 (7.3%)、胃がん (5.6%)。肺がんは依然としてがんによる死亡の主な原因であり、推定 180 万人 (18%) が死亡し、続いて結腸直腸がん (9.4%)、肝臓 (8.3%)、胃 (7.7%)、女性の乳がん (6.9%) が続きました。全体的な発生率は、移行国よりも移行国で 2 倍から 3 倍高かった。しかし、女性の乳がんと子宮頸がんによる死亡は、移行国よりも移行国の方がかなり高かった。このように癌の有病率が高いため、研究や研究のための凍結組織サンプルの必要性が高まっています。凍結腫瘍組織サンプルを使用した研究の増加により、この慢性疾患のいくつかの診断および治療範囲が確立されています。したがって、世界中で癌の発生率が上昇していることは、凍結組織サンプル市場の成長に拍車をかけています。さらに、カナダでは、がんが人口の主要な死因であり、米国では心臓病に次いで 2 番目に多い死因であることが証明されています。米国癌協会によると、2022 年には米国で約 190 万人の新たな癌症例が診断され、609,360 人の死亡が推定されています。前立腺癌は、北米の男性の間で最も一般的に診断される癌です。ただし、乳がんは依然として女性をリードしています。さらに、肺がんは依然として人口の中で最も一般的な死因です。癌の発生率の新規症例数は、年間 100,000 人の男性および女性あたり 439.2 人であると推定されています。したがって、人口におけるがんの有病率の増加は、世界中の凍結組織サンプル市場の成長につながっています。
製品ベースの洞察
製品に基づく世界の凍結組織サンプル市場は、凍結正常組織サンプル、凍結腫瘍組織サンプル、および凍結疾患組織サンプルに分割されます。凍結組織腫瘍サンプル セグメントは、2021 年に市場で最大のシェアを占めました。さらに、同じセグメントは、2021 年から 2028 年の予測期間中に凍結組織サンプル市場で最高の CAGR を記録すると予想されます。成長は主に、世界中で腫瘍の症例が増加しています。
凍結組織サンプル市場、製品別 - 2021 年および 2028 年
アプリケーションベースの洞察
アプリケーションに基づいて、世界の凍結組織サンプル市場は、疾患の診断と治療、癌およびその他の疾患の研究、形態学的分析に分割されます。 2021年、がんおよびその他の疾患研究セグメントは、世界の凍結組織サンプル市場で最大のシェアを占めました。ただし、疾患の診断と治療のセグメントは、2021 年から 2028 年にかけて 13.8% という最速の CAGR で成長すると予想されています。
エンド ユーザー ベースのインサイト
世界の凍結組織サンプル市場は、エンドユーザーに基づいて、学術および研究機関、病院および診療所、診断センターなどに分割されています。 2021年には、学術および研究機関セグメントが世界の凍結組織サンプル市場で最大のシェアを占めました。ただし、病院と診療所のセグメントは、2021 年から 2028 年にかけて 13.9% という最速の CAGR で成長すると予想されます。
製品の発売と承認は、企業がグローバル展開を拡大するために一般的に採用する戦略です。フットプリントと製品ポートフォリオ。さらに、凍結組織サンプル市場のプレーヤーは、顧客を拡大するためのパートナーシップ戦略に焦点を当てており、これにより、ブランド名をグローバルに維持することができます。世界の凍結組織サンプル市場は、市場関係者による新しい革新的な製品の開発により繁栄すると予想されます。
会社概要
- < TIP>
- Audubon Bioscience Co
- REPROCELL Inc.
- Bay Biosciences LLC
- US Biolab Corporation, Inc.< /li>
- AMS Biotechnology (Europe) Ltd.
- Geneticist, Inc.
- ZenBio, Inc.
- BioChain Institute Inc.
- ProteoGenex, Inc.
< li>OriGene Technologies, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Frozen tissue samples are biospecimens preferred in analyses such as next-generation sequencing, western blotting for post-translational protein modifications, mass spectrometry, and quantitative real-time polymerase chain reaction. Frozen tissue samples are the gold standard for DNA and RNA sequencing, especially when the strands must be longer than 50 pairs. In immunohistochemistry, frozen tissue samples are also useful as the proteins are still preserved in their native state.
The factors that are driving the growth of the market are rising application of frozen tissue samples in various research and therapeutic areas and risk associated with preservation and maintenance of frozen tissues samples. Moreover, the proliferation of biotechnology industry in developing regions provide growth opportunities to the frozen tissues samples market and developments in frozen tissue samples is expected to be a future trend that will drive the market’s growth in the coming years.
The frozen tissue tumor samples segment was likely to hold the largest share of the market in 2021. Moreover, the same segment is anticipated to register the highest CAGR in the market during the forecast period of 2021 to 2028. The growth is mainly attributed due to increasing tumor cases globally.
In 2021, the academic and research institutes segment was likely to hold the largest share of the market. However, the hospitals and clinics segment is expected to witness growth in its demand at the fastest CAGR of 13.8% during 2021 to 2028.
The global Frozen Tissues Samples market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. Increasing incidence of cancer, growing need for diagnosing cancer, increasing competition between the market player, high R&D spending, and government grants for research institutes to develop new diagnosing methods are some of the prominent factors propelling the market growth in North America. Moreover, owing to the growing investments from international players in China and India. Aging population coupled with increasing demand for advanced medical technologies are expected to accelerate growth of the frozen tissues samples Market in Asia Pacific region.
The Frozen Tissues Samples market majorly consists of the players such as Audubon Bioscience Co; REPROCELL Inc.; Bay Biosciences LLC; US Biolab Corporation, Inc; AMS Biotechnology (Europe) Ltd.; Geneticist, Inc.; ZenBio, Inc.; OriGene Technologies, Inc.; BioChain Institute Inc.; and ProteoGenex, Inc., among others.
The List of Companies - Frozen Tissues Samples Market
- Audubon Bioscience Co
- REPROCELL Inc.
- Bay Biosciences LLC
- US Biolab Corporation, Inc.
- AMS Biotechnology (Europe) Ltd.
- Geneticist, Inc.
- ZenBio, Inc.
- OriGene Technologies, Inc.
- BioChain Institute Inc.
- ProteoGenex, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2022
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2022
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2022
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2022
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2022
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2022
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)